BriaCell Therapeutics Corp (BCTXW) — Financial Flexibility Index
BriaCell Therapeutics Corp (BCTXW) has a Financial Flexibility Index of -2.41x as of January 2026. Free cash flow of $-8.09 Million (operating CF $-8.09 Million minus capex $0.00) represents -2% of total liabilities ($3.35 Million). Check how strategically is BriaCell Therapeutics Corp's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BriaCell Therapeutics Corp Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for BriaCell Therapeutics Corp across 20 annual periods. See BCTXW working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for BriaCell Therapeutics Corp (2006–2025)
Year-by-year free cash flow to debt coverage for BriaCell Therapeutics Corp. For the full company profile including market capitalisation, see BriaCell Therapeutics Corp (BCTXW) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -6.53x | $-28.17 Million | $-28.17 Million | $4.32 Million | ▼ -136.0% |
| 2024 | -2.77x | $-23.67 Million | $-24.13 Million | $8.56 Million | ▼ -260.4% |
| 2023 | -0.77x | $-23.74 Million | $-23.74 Million | $30.94 Million | ▼ -98.2% |
| 2022 | -0.39x | $-12.48 Million | $-12.48 Million | $32.25 Million | ▲ +96.1% |
| 2021 | -9.90x | $-7.75 Million | $-7.75 Million | $782.24K | ▼ -3123.4% |
| 2020 | -0.31x | $-1.16 Million | $-1.16 Million | $3.77 Million | ▲ +91.6% |
| 2019 | -3.66x | $-3.87 Million | $-3.87 Million | $1.06 Million | ▼ -28.8% |
| 2018 | -2.84x | $-3.81 Million | $-3.81 Million | $1.34 Million | ▼ -63.9% |
| 2017 | -1.73x | $-1.54 Million | $-1.54 Million | $885.90K | ▲ +93.0% |
| 2016 | -24.68x | $-1.20 Million | $-1.20 Million | $48.59K | ▼ -209.7% |
| 2015 | -7.97x | $-933.52K | $-935.26K | $117.17K | ▼ -6563.5% |
| 2014 | -0.12x | $-219.72K | $-363.97K | $1.84 Million | ▼ -112.2% |
| 2013 | 0.98x | $73.24K | $-368.52K | $74.46K | ▼ -86.9% |
| 2012 | 7.49x | $2.13 Million | $-381.49K | $283.94K | ▲ +137.2% |
| 2011 | 3.16x | $1.77 Million | $-690.76K | $559.43K | ▼ -46.5% |
| 2010 | 5.91x | $172.30K | $-309.37K | $29.15K | ▲ +369.8% |
| 2009 | -2.19x | $-140.59K | $-140.59K | $64.19K | ▲ +60.8% |
| 2008 | -5.59x | $-87.41K | $-87.41K | $15.64K | ▲ +39.0% |
| 2007 | -9.16x | $-87.76K | $-87.76K | $9.58K | ▼ -13543.1% |
| 2006 | 0.07x | $1.13K | $1.13K | $16.54K | — |